Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 25.03.2021.

#biotechnology
#COVID19
#biospace
#lifesciences
#pharmaceuticals
#coronavirus
#clinicaltrials
#treatment
#COVID
#pandemic

Companies And Industries

@BiotechWorld shared
On Mar 19, 2021
How Five Prime suitor Amgen battled multiple companies for its biotech—and won https://t.co/vGYI1Gvgkj https://t.co/nZUBVODNNx
Open
How Five Prime suitor Amgen battled multiple companies for the biotech—and won

How Five Prime suitor Amgen battled multiple companies for the biotech—and won

It’s that time when the company bought out by a parent files the saga with the SEC, and, with Amgen and Five Prime Therapeutics, we found out Amgen was not the only interested party.

@biospace shared
On Mar 23, 2021
@OramedPharma Forms Joint Venture Company to Develop Oral COVID-19 Vaccines #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment https://t.co/1RCYcCLFJC
Open
Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines

Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines

Jerusalem’s clinical-stage pharmaceutical company Oramed Pharmaceuticals is forming a joint venture with Premas Biotech to develop novel oral COVID-19 vaccine candidates.

@BiotechWorld shared
On Mar 24, 2021
Pfizer taps HIV, hep C antiviral research for COVID-19 pill trial https://t.co/vzS1x6cmy3 https://t.co/GcDa4xSxbo
Open
Pfizer taps HIV, hep C antiviral research for COVID-19 pill trial

Pfizer taps HIV, hep C antiviral research for COVID-19 pill trial

Pfizer has already seen major success with its BioNTech-partnered COVID-19 vaccine, but, now, the Big Pharma is hoping to add to the arsenal with a pandemic pill using old antiviral ...

@matthewherper shared
On Mar 23, 2021
$REGN data from earlier. https://t.co/t5llHlHIt9
Open
Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients

Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients

TARRYTOWN, N.Y. , March 23, 2021 /PRNewswire/ --  REGEN-COV also significantly shortened the duration of symptoms by 4 days All doses (8,000 mg, 2,400 mg and 1,200 mg) had similar efficacy ...

@BiotechWorld shared
On Mar 24, 2021
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO https://t.co/RVH2BgM5S1 https://t.co/XB6eesL5Ie
Open
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Inotrem has named Sven Zimmermann as CEO. Zimmermann joins the inflammatory disease biotech after overseeing a series of deals at former employers including Novimmune’s asset sale to Sobi ...

@pharmaphorum shared
On Mar 25, 2021
GlaxoSmithKline fires former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it majority owns, after an internal investigation found he sexually harassed a female employee https://t.co/jQ6GMtBZNm #pharma
Open
GSK fires former R&D chief Slaoui after sexual harassment allegation

GSK fires former R&D chief Slaoui after sexual harassment allegation

GlaxoSmithKline has fired its former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it majority owns, after an internal investigation found he sexually ...

@CellCultureDish shared
On Mar 19, 2021
Weekly Biotechnology News Wrap-Up - 03/19/2021 - https://t.co/5L07dEnvj3
Open
The Dish’s Weekly Biotechnology News Wrap Up – March 19, 2021

The Dish’s Weekly Biotechnology News Wrap Up – March 19, 2021

*|RSSFEED:DATE|* Incase you missed it. We summarized the week's top biotechnology stories.

@biospace shared
On Mar 20, 2021
Three Biopharma Companies Debut on the Nasdaq, Raise Combined $356 Million in IPOs #biospace #lifesciences #biotechnology #pharmaceuticals https://t.co/UTyoIbrvhD
Open
Three Biopharma Companies Debut on the Nasdaq, Raise Combined $356 Million in IPOs

Three Biopharma Companies Debut on the Nasdaq, Raise Combined $356 Million in IPOs

It’s been another strong week of biopharma companies making their debut on a stock exchange. Over the past 48 hours, three companies, Finch Therapeutics, Connect Biopharma and Gain ...